These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 7237894
1. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure. Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH. Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894 [Abstract] [Full Text] [Related]
2. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose. Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV. Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126 [Abstract] [Full Text] [Related]
6. Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure. Leier CV, Desch CE, Magorien RD, Triffon DW, Unverferth DV, Boudoulas H, Lewis RP. Am J Cardiol; 1980 Dec 01; 46(6):1039-44. PubMed ID: 7446418 [Abstract] [Full Text] [Related]
7. Development of pharmacodynamic tolerance to prozosin in congestive heart failure. Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV. Am J Cardiol; 1979 Nov 01; 44(6):1178-82. PubMed ID: 495512 [Abstract] [Full Text] [Related]
8. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Rouleau JL, Chatterjee K, Benge W, Parmley WW, Hiramatsu B. Circulation; 1982 Apr 01; 65(4):671-8. PubMed ID: 7037220 [No Abstract] [Full Text] [Related]
9. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure. Mehta J, Iacona M, Pepine CJ, Conti CR. Br Heart J; 1979 Dec 01; 42(6):664-70. PubMed ID: 534583 [Abstract] [Full Text] [Related]
10. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Packer M, Meller J, Gorlin R, Herman MV. Circulation; 1979 Mar 01; 59(3):531-9. PubMed ID: 761333 [No Abstract] [Full Text] [Related]
11. Attenuation of prazosin effect on cardiac output in chronic heart failure. Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K. Ann Intern Med; 1979 Sep 01; 91(3):345-9. PubMed ID: 475164 [Abstract] [Full Text] [Related]
18. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. Gogia H, Mehra A, Parikh S, Raman M, Ajit-Uppal J, Johnson JV, Elkayam U. J Am Coll Cardiol; 1995 Dec 01; 26(7):1575-80. PubMed ID: 7594088 [Abstract] [Full Text] [Related]
19. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. Rubin SA, Chatterjee K, Gelberg HJ, Ports TA, Brundage BH, Parmley WW. Am J Cardiol; 1979 Apr 01; 43(4):810-5. PubMed ID: 425918 [Abstract] [Full Text] [Related]
20. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure. Feldman RC, Ball RM, Winchester MA, Jaillon P, Kates RE, Harrison DC. Am Heart J; 1981 May 01; 101(5):534-40. PubMed ID: 7223593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]